These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 25084219)
1. Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice. Yamamoto S; Gotoh M; Kawamura Y; Yamashina K; Yagishita S; Awaji T; Tanaka M; Maruyama K; Murakami-Murofushi K; Yoshikawa K Eur J Pharmacol; 2014 Oct; 741():17-24. PubMed ID: 25084219 [TBL] [Abstract][Full Text] [Related]
2. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease. Yamamoto S; Yamashina K; Ishikawa M; Gotoh M; Yagishita S; Iwasa K; Maruyama K; Murakami-Murofushi K; Yoshikawa K J Neuroinflammation; 2017 Jul; 14(1):142. PubMed ID: 28732510 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model. Iwasa K; Yamamoto S; Takahashi M; Suzuki S; Yagishita S; Awaji T; Maruyama K; Yoshikawa K Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):175-82. PubMed ID: 25224839 [TBL] [Abstract][Full Text] [Related]
4. A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination. Torkildsen Ø; Brunborg LA; Milde AM; Mørk SJ; Myhr KM; Bø L Clin Nutr; 2009 Feb; 28(1):83-7. PubMed ID: 19042061 [TBL] [Abstract][Full Text] [Related]
5. Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice. Hoffmann K; Lindner M; Gröticke I; Stangel M; Löscher W Exp Neurol; 2008 Apr; 210(2):308-21. PubMed ID: 18096162 [TBL] [Abstract][Full Text] [Related]
6. Adult CNP::EGFP transgenic mouse shows pronounced hypomyelination and an increased vulnerability to cuprizone-induced demyelination. Millet V; Marder M; Pasquini LA Exp Neurol; 2012 Jan; 233(1):490-504. PubMed ID: 22155618 [TBL] [Abstract][Full Text] [Related]
7. The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation. Hashimoto M; Yamamoto S; Iwasa K; Yamashina K; Ishikawa M; Maruyama K; Bosetti F; Yoshikawa K Brain Res Bull; 2017 Oct; 135():47-52. PubMed ID: 28923306 [TBL] [Abstract][Full Text] [Related]
8. Pathological changes in mice with long term cuprizone administration. Nomura T; Bando Y; Nakazawa H; Kanemoto S; Yoshida S Neurochem Int; 2019 Jun; 126():229-238. PubMed ID: 30940543 [TBL] [Abstract][Full Text] [Related]
9. Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model. Nunes AK; Rapôso C; Luna RL; Cruz-Höfling MA; Peixoto CA Cytokine; 2012 Nov; 60(2):540-51. PubMed ID: 22749439 [TBL] [Abstract][Full Text] [Related]
10. Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination. Hoyos HC; Rinaldi M; Mendez-Huergo SP; Marder M; Rabinovich GA; Pasquini JM; Pasquini LA Neurobiol Dis; 2014 Feb; 62():441-55. PubMed ID: 24184798 [TBL] [Abstract][Full Text] [Related]
11. Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1. Yamamoto S; Sakemoto C; Iwasa K; Maruyama K; Shimizu K; Yoshikawa K J Pharmacol Sci; 2020 Nov; 144(3):119-122. PubMed ID: 32921392 [TBL] [Abstract][Full Text] [Related]
12. Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage. Liu J; Tian D; Murugan M; Eyo UB; Dreyfus CF; Wang W; Wu LJ J Neurochem; 2015 Oct; 135(2):347-56. PubMed ID: 26173779 [TBL] [Abstract][Full Text] [Related]
13. Demyelination of the hippocampus is prominent in the cuprizone model. Koutsoudaki PN; Skripuletz T; Gudi V; Moharregh-Khiabani D; Hildebrandt H; Trebst C; Stangel M Neurosci Lett; 2009 Feb; 451(1):83-8. PubMed ID: 19084049 [TBL] [Abstract][Full Text] [Related]
14. Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. Franco-Pons N; Torrente M; Colomina MT; Vilella E Toxicol Lett; 2007 Mar; 169(3):205-13. PubMed ID: 17317045 [TBL] [Abstract][Full Text] [Related]
15. Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Liebetanz D; Merkler D Exp Neurol; 2006 Nov; 202(1):217-24. PubMed ID: 16857191 [TBL] [Abstract][Full Text] [Related]
16. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. Irvine KA; Blakemore WF J Neuroimmunol; 2006 Jun; 175(1-2):69-76. PubMed ID: 16626812 [TBL] [Abstract][Full Text] [Related]
17. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606 [TBL] [Abstract][Full Text] [Related]
18. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle. Taylor LC; Gilmore W; Ting JP; Matsushima GK J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424 [TBL] [Abstract][Full Text] [Related]
19. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination. Acs P; Komoly S Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847 [TBL] [Abstract][Full Text] [Related]
20. Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss. Doan V; Kleindienst AM; McMahon EJ; Long BR; Matsushima GK; Taylor LC J Neurosci Res; 2013 Mar; 91(3):363-73. PubMed ID: 23280518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]